Early-onset leukoencephalopathy due to a homozygous missense mutation in the DARS2 gene

Mol Cell Probes. 2015 Oct;29(5):319-22. doi: 10.1016/j.mcp.2015.06.005. Epub 2015 Aug 29.

Abstract

Mutations in the DARS2 gene are known to cause leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL), a rare autosomal recessive neurological disorder. It was originally described as juvenile-onset slowly progressive ataxia and spasticity, but recent reports suggest a broader clinical spectrum. Most patients were found to carry compound heterozygous DARS2 mutations, and only very few patients with homozygous mutations have been described so far. We present here an 8-month-old boy carrying a homozygous missense mutation in DARS2 who clinically showed severe neurological deterioration after a respiratory tract infection, followed by an almost complete remission of symptoms. This report further extends the knowledge about the clinical and molecular genetic spectrum of LBSL.

Keywords: DARS2; LBSL; Leukoencephalopathy; Magnetic resonance imaging; Mitochondriopathy.

Publication types

  • Case Reports

MeSH terms

  • Age of Onset
  • Aspartate-tRNA Ligase / genetics*
  • Genetic Predisposition to Disease
  • Homozygote
  • Humans
  • Infant
  • Leukoencephalopathies / diagnosis
  • Leukoencephalopathies / genetics*
  • Male
  • Mutation, Missense*
  • Pedigree
  • Sequence Analysis, DNA

Substances

  • Aspartate-tRNA Ligase
  • DARS2 protein, human